Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

Trial Profile

Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 May 2017

At a glance

  • Drugs Plerixafor (Primary) ; Antineoplastics
  • Indications Chronic lymphocytic leukaemia; Lymphoma; Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2015 Planned End Date changed from 1 May 2016 to 1 Sep 2017 as reported by ClinicalTrials.gov.
    • 02 Dec 2015 Planned primary completion date changed to 1 Mar 2017 as reported by ClinicalTrials.gov.
    • 10 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top